Shanghai Henlius Biotech (HKSE:02696) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shanghai Henlius Biotech's Free Cash Flow for the three months ended in Dec. 2023 was HK$0 Mil. Shanghai Henlius Biotech's Revenue for the three months ended in Dec. 2023 was HK$1,605 Mil. Therefore, Shanghai Henlius Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Shanghai Henlius Biotech's current FCF Yield % is 0.44%.

The historical rank and industry rank for Shanghai Henlius Biotech's FCF Margin % or its related term are showing as below:

HKSE:02696' s FCF Margin % Range Over the Past 10 Years
Min: -10612.17 Med: -361.16 Max: 1.27
Current: 1.27

During the past 7 years, the highest FCF Margin % of Shanghai Henlius Biotech was 1.27%. The lowest was -10612.17%. And the median was -361.16%.

HKSE:02696's FCF Margin % is ranked better than
80.62% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs HKSE:02696: 1.27

Shanghai Henlius Biotech FCF Margin % Historical Data

The historical data trend for Shanghai Henlius Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Henlius Biotech FCF Margin % Chart

Shanghai Henlius Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,733.28

-361.16

-61.86

-11.93

0.68

Shanghai Henlius Biotech Quarterly Data
	Dec17	Mar18	Jun18	Dec18	Mar19	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Shanghai Henlius Biotech's FCF Margin %

For the Biotechnology subindustry, Shanghai Henlius Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Henlius Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Henlius Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Henlius Biotech's FCF Margin % falls into.

Shanghai Henlius Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Shanghai Henlius Biotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	39.898	/	5900.838
	=	0.68 %

Shanghai Henlius Biotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	1604.682
	=	0.00 %

Shanghai Henlius Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech (HKSE:02696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1801 Hongmei Road, 9th Floor, Innov Tower (Capitaland Building), Xuhui District, Shanghai, CHN, 200233

Website

https://www.henlius.com

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China and Overseas. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Shanghai Henlius Biotech (HKSE:02696) Headlines

No Headlines